Genetically Modified Mesenchymal Stem Cell Therapy (Head and Neck Cancer)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Genetically Modified Mesenchymal Stem Cell Therapy (Head and Neck Cancer), covering 2025-08-22 to 2025-08-22. Get the full timeline:
Most recent: Clinical Trial Update: Genetically Modified Mesenchymal Stem Cell Theraopeutic Against Head and Neck Cancer [Phase 1]